About a conference
Dear Colleagues and Friends, Ladies and Gentlemen!
We are happy to welcome you in St. Petersburg at the 8th Raisa Gorbacheva Memorial Meeting “Hematopoietic Stem Cell Transplantation in Children and Adults”.
It is our privilege to greet famous hematologists, oncologists and researchers in the field of hematopoietic stem cell transplantation, as well as all the participants and guests of the Meeting which is now arranged in the historical district of our beautiful City.
Some key concepts of stem cell science were discovered and developed by the brilliant Russian scientist A. Maximov at the Military Medical Academy, which is located just round the corner from Meeting venue. Later on, after pioneering studies of Till and McCulloch, Pluznick and Sachs, Bradley and Metcalf, our Medical University has taken up their ideas and approaches. For several decades, this focus area remains among priorities of our research. Recent advances in hematopoietic stem cell transplantation at First Pavlov State Medical University of St. Petersburg are determined by two main factors: invaluable aid of M.S. Gorbachev in arrangement of the Raisa Gorbacheva Memorial Research Institute for Pediatric Oncology, Hematology and Transplantation, as well as international cooperationand support from our outstanding colleagues.
Raisa Gorbacheva Memorial Meeting is the most significant annual event for hematologists, oncologists and specialists in hematopoietic stem cell transplantation in Russia. Let us express our deep gratitude to all the speakers at this Meeting, with their knowledge and authority which attract us to this hall, including S. Aleksanin, O. Aleynikova, A. Alaynskiy, J. Apperley, A. Baranov, I. Barkhatov, V. Baykov, M. Borset, L. Bubnova, T. Büchner, A. Chechetkin, B. Fehse, W. Fibbe, J. Glover, A. Grebenyuk, R. Hehlmann, D. H.lzer, N. Klimko, H.J. Kolb, V. Kostyukovskiy, N. Kr.ger, J. Kuball, A. Kulagin, C. Lange, I. Lisukov, A. Madrigal, A. Maschan, N. Mikhailova, S. Moiseev, E. Morozova, A. Nagler, A. Nemkov, I. Pavlova, I. Paramonov, B. Pinto Simoes, I. Pivovarova, M. Popova, R. Powles, V. Ptushkin, S. Raisov, T. Ruutu, A. Sureda, T. Suslova, J. van Lunzen, A. Volkova, G. Wagemaker, A. Zander A., A. Zaritsky.
With advent of new targeted drugs, HSCT, however, remains the only curative option for many malignancies, hematological and inherited disorders. To date, over 1.000.000 HSCTs were performed worldwide. The registries of unrelated donors contain relevant information near 24 million potential donors and more than 600.000 cord blood units are stored in public cord blood banks. HSCT technologies are developing rapidly and recent advances include the changing clinical indications, new conditioning regimens, developments in GVHD prophylaxis and treatment, cell therapy etc. All of this needs permanent maintenance of knowledge, thus determining the main goal of our Meeting.
This year the Program of our Symposium is accomplished with two new sessions “HSCT and HIV” and “Radiation hematology”. Following successful treatment of patient with acute leukemia and HIV infection by HSCT from a donor homozygous for CCR5 delta32 (“The Berlin patient”), this curative approach attracted great interest among specialists in cellular and gene therapy of cancer patients with HIV infection. A special section of our Symposium will be dedicated to the most relevant clinical aspects of radiation effects.
We would like to wish productive discussions, as well as new creative contacts and pleasant stay in St. Petersburg to all participants and guests.